A coordinated PCP-Cardiologist Telemedicine Model (PCTM) in China's community hypertension care: Study protocol for a randomized controlled trial

Trials

Volumn 18, Issue 1, 2017, Pages

  Xu, Lei ^a   Fang, Wei Yi ^a   Zhu, Fu ^b   Zhang, Hong Guang ^c   Liu, Kai ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Shanghai CareLinker Medical Technology Co Ltd   (China)

Author keywords

Hypertension; Medication adherence; Primary care; Randomized controlled trial; Telemedicine

Indexed keywords

ARTICLE; CARDIOLOGIST; CHINA; COMMUNITY CARE; CONTROLLED STUDY; DISEASE CONTROL; GENERAL PRACTITIONER; HEALTH CENTER; HOME CARE; HUMAN; HYPERTENSION; OUTCOME ASSESSMENT; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TELEMEDICINE; TELEMONITORING; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL PROTOCOL; CLINICAL TRIAL; COOPERATION; DRUG EFFECTS; GEOGRAPHIC INFORMATION SYSTEM; INTEGRATED HEALTH CARE SYSTEM; INTERDISCIPLINARY COMMUNICATION; MEDICATION COMPLIANCE; METHODOLOGY; MOBILE APPLICATION; MOBILE PHONE; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; TELEMETRY; TIME FACTOR; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOLOGISTS; CELL PHONE; CHINA; CLINICAL PROTOCOLS; COMMUNITY HEALTH SERVICES; COOPERATIVE BEHAVIOR; DELIVERY OF HEALTH CARE, INTEGRATED; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; HYPERTENSION; INTERDISCIPLINARY COMMUNICATION; MEDICATION ADHERENCE; MOBILE APPLICATIONS; PATIENT CARE TEAM; PHYSICIANS, PRIMARY CARE; RESEARCH DESIGN; TELEMEDICINE; TELEMETRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 85019589609     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-1970-z     Document Type: Article

References (55)

1. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987-2015.
2. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
3. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24(2):215-33.
4. Sundstrom J, Arima H, Woodward M, Jackson R, Karmali K, Lloyd-Jones D, et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384(9943):591-8.
5. Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens. 2015;9(2):130-6.
6. Quinn CC, Clough SS, Minor JM, Lender D, Okafor MC, Gruber-Baldini A. WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008;10(3):160-8.
7. Pfaeffli Dale L, Whittaker R, Jiang Y, Stewart R, Rolleston A, Maddison R. Text message and Internet support for coronary heart disease self-management: results From the Text4Heart randomized controlled trial. J Med Internet Res. 2015;17(10):e237.
8. Fernandez-Granero MA, Sanchez-Morillo D, Leon-Jimenez A. Computerised analysis of telemonitored respiratory sounds for predicting acute exacerbations of COPD. Sensors (Basel). 2015;15(10):26978-96.
9. Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011;34(9):1934-42.
10. Omboni S, Caserini M, Coronetti C. Telemedicine and m-health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev. 2016;23(3):187-96.
11. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455-67.
12. Quinn CC, Gruber-Baldini AL, Shardell M, Weed K, Clough SS, Peeples M, et al. Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control. Contemp Clin Trials. 2009;30(4):334-46.
13. Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr EA, Gruber-Baldini AL. Mobile diabetes intervention for glycemic control: impact on physician prescribing. J Diabetes Sci Technol. 2014;8(2):362-70.
14. Quinn CC, Shardell MD, Terrin ML, Barr EA, Park D, Shaikh F, et al. Mobile diabetes intervention for glycemic control in 45- to 64-year-old persons with type 2 diabetes. J Appl Gerontol. 2016;35(2):227-43.
15. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA, et al. A successful multifaceted trial to improve hypertension control in primary care: why did it work? J Gen Intern Med. 2015;30(11):1665-72.
16. O'Connor PJ, Schmittdiel JA, Pathak RD, Harris RI, Newton KM, Ohnsorg KA, et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care. 2014;37(12):3317-24.
17. Weltermann B, Viehmann A, Kersting C. Hypertension management in primary care: study protocol for a cluster randomized controlled trial. Trials. 2015;16:105.
18. Heisler M, Hofer TP, Klamerus ML, Schmittdiel J, Selby J, Hogan MM, et al. Study protocol: the Adherence and Intensification of Medications (AIM) study-a cluster randomized controlled effectiveness study. Trials. 2010;11:95.
19. Xu L, Zhang Y, Chen Y, Li YJ, Chen D, Wang T, et al. The role of pharmacist-led hypertension management in China's community medical care service: a retrospective analysis of real-world big-data samples. Precision Med Cardiol. 2016;1(1):19-26.
20. Oliveira-Filho AD, Barreto-Filho JA, Neves SJ, Lyra Junior DP. Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control. Arq Bras Cardiol. 2012;99(1):649-58.
21. Liu LS. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579-615.
22. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
23. Zhang HG, Liu K, Kong WJ, Tian F, Yang YR, Feng C, et al. A mobile health solution for chronic disease managment at retail pharmacy. 2016 IEEE 18th International Conference on e-Health Networking, Applications and Services (Healthcom). 2016. p.1-5. doi: 10.1109/HealthCom.2016.7749455.
24. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation. 2006;114(21):2217-25.
25. Collaborative Group. A study on evaluation of the risk of ischemic cardiovascular diseases in Chinese and the development of simplified tools for the evaluation. Chin J Cardiol. 2003;31(12):893-901.
26. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, et al. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26(7):478-84.
27. Sheng CS, Liu M, Kang YY, Wei FF, Zhang L, Li GL, et al. Prevalence, awareness, treatment and control of hypertension in elderly Chinese. Hypertens Res. 2013;36(9):824-28.
28. Wang L, Kong L, Wu F, Bai Y, Burton R. Preventing chronic diseases in China. Lancet. 2005;366(9499):1821-24.
29. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC, et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372(9650):1697-705.
30. Hallberg I, Taft C, Ranerup A, Bengtsson U, Hoffmann M, Hofer S, et al. Phases in development of an interactive mobile phone-based system to support self-management of hypertension. Integr Blood Press Control. 2014;7:19-28.
31. Glynn LG, Hayes PS, Casey M, Glynn F, Alvarez-Iglesias A, Newell J, et al. SMART MOVE - a smartphone-based intervention to promote physical activity in primary care: study protocol for a randomized controlled trial. Trials. 2013;14:157.
32. Zullig LL, Melnyk SD, Goldstein K, Shaw RJ, Bosworth HB. The role of home blood pressure telemonitoring in managing hypertensive populations. Curr Hypertens Rep. 2013;15(4):346-55.
33. Kirwan M, Vandelanotte C, Fenning A, Duncan MJ. Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial. J Med Internet Res. 2013;15(11):e235.
34. Logan AG, Irvine MJ, McIsaac WJ, Tisler A, Rossos PG, Easty A, et al. Effect of home blood pressure telemonitoring with self-care support on uncontrolled systolic hypertension in diabetics. Hypertension. 2012;60(1):51-7.
35. Stoddart A, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open. 2013;3(5). doi: 10.1136/bmjopen-2013-002681.
36. Thiboutot J, Sciamanna CN, Falkner B, Kephart DK, Stuckey HL, Adelman AM, et al. Effects of a web-based patient activation intervention to overcome clinical inertia on blood pressure control: cluster randomized controlled trial. J Med Internet Res. 2013;15(9):e158.
37. Kim JY, Wineinger NE, Steinhubl SR. The influence of wireless self-monitoring program on the relationship between patient activation and health behaviors, medication adherence, and blood pressure levels in hypertensive patients: a substudy of a randomized controlled trial. J Med Internet Res. 2016;18(6):e116.
38. Hosseininasab M, Jahangard-Rafsanjani Z, Mohagheghi A, Sarayani A, Rashidian A, Javadi M, et al. Self-monitoring of blood pressure for improving adherence to antihypertensive medicines and blood pressure control: a randomized controlled trial. Am J Hypertens. 2014;27(11):1339-45.
39. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163-72.
40. Hirsch JD, Steers N, Adler DS, Kuo GM, Morello CM, Lang M, et al. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36(9):1244-54.
41. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996-2002.
42. Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8(3):235-43.
43. O'Neill JL, Cunningham TL, Wiitala WL, Bartley EP. Collaborative hypertension case management by registered nurses and clinical pharmacy specialists within the Patient Aligned Care Teams (PACT) model. J Gen Intern Med. 2014;29 Suppl 2:S675-81.
44. Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23(12):1966-72.
45. Qudah B, Albsoul-Younes A, Alawa E, Mehyar N. Role of clinical pharmacist in the management of blood pressure in dialysis patients. Int J Clin Pharm. 2016;38(4):931-40.
46. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299(24):2857-67.
47. Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013;6(2):157-63.
48. Green BB, Anderson ML, Ralston JD, Catz SL, Cook AJ. Blood pressure 1 year after completion of web-based pharmacist care. JAMA Intern Med. 2013;173(13):1250-2.
49. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46-56.
50. Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther. 2015;13(2):209-21.
51. Lee P, Liu JC, Hsieh MH, Hao WR, Tseng YT, Liu SH, et al. Cloud-based BP system integrated with CPOE improves self-management of the hypertensive patients: a randomized controlled trial. Comput Methods Programs Biomed. 2016;132:105-13.
52. Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens. 2011;24(9):989-98.
53. van Vugt M, de Wit M, Cleijne WH, Snoek FJ. Use of behavioral change techniques in web-based self-management programs for type 2 diabetes patients: systematic review. J Med Internet Res. 2013;15(12):e279.
54. AbuDagga A, Resnick HE, Alwan M. Impact of blood pressure telemonitoring on hypertension outcomes: a literature review. Telemed J E Health. 2010;16(7):830-8.
55. Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffe P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2):e000718.